Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Anxiety disorders, as a group, are among the most common mental health conditions and
frequently cause significant functional impairment. Both psychotherapeutic and …

Objective: To provide practical clinical guidance for the treatment of adults with panic
disorder, social anxiety disorder and generalised anxiety disorder in Australia and New …

The Massachusetts General Hospital is widely respected as one of the world's premier
psychiatric institutions. Now, preeminent authorities from MGH present the newly updated …

Aging is, by far, the greatest risk factor for most neurodegenerative diseases. In non-
diseased conditions, normal aging can also be associated with declines in cognitive function …

In this review, the author examines the evidence for psychopharmacologic treatments
among adults for generalized anxiety disorder, panic disorder, and social anxiety disorder …

Several pharmacological targets have been proposed as modulators of panic-like reactions.
However, interest should be given to other potential therapeutic neurochemical agents …

The evidence-based pharmacotherapy of panic disorder continues to evolve. This paper
reviews data on first-line pharmacotherapy, evidence for maintenance treatment, and …

Abstract Purpose Panic Disorder (PD) is a classic example of a disease where symptom
remission may be achieved, yet patient quality of life (QOL) remains low, providing further …

BACKGROUND: Panic disorder (PD) is a devastating illness, with numerous patients
experiencing significant functional disability and many not achieving full remission with first …